3T3-L1 preadipocytes |
Differentiation↑, IBMX↑, insulin↑, STAT 5↑, PPARγ2↓, p-CREB↓ |
[36] |
Intracellular triglyceride↓, adiponectin↑, MCP-1↓, resistin↓ |
[7] |
Lipid accumulation↓, GPDH↓, PPARγ↓, C/EBPα↓, AMPK↑ |
[38] |
|
3T3-F442A adipocytes |
Glucose uptake↑, PI3K/Akt1/2↑, PKA/CREB signaling↑ |
[35] |
|
3XTg-AD mice model |
Soluble Aβ
1-40 production↓ |
[13] |
|
A2780/T cells |
ABCB1 transporter efflux↓, Akt/ERK/Nrf2↓ |
[89] |
|
AGS cells |
MMP-2↓, MMP-9↓, c-Raf↓, Ras↓, Rac-1↓, RhoA↓, Cdc42↓, PI3K/Akt signaling↓, FAK activation↓, NF-κB signaling↓ |
[5] |
|
BV2 microglia cells |
IL-1β↓, TNFα↓, IL-6↓, NO↓ |
[47] |
|
C6 glioma cells |
cellular proliferation↓, Ras activity↓, MEK/ERK signaling↓ |
[25] |
|
CUMS-induced rats |
BDNF↑, TrkB↑, synapsin I↑ |
[28] |
|
Diet-induced obese mice |
Energy expenditure↑, locomotor activity↑, metabolic disorders↓, circadian rhythms↑ |
[52] |
|
DU-145 cells |
cMyc↓, p50↓ |
[58] |
|
Freshly isolated hepatocytes |
SCD1 mRNA expression↓, hyperlipidemia↓, adiposity↓ |
[37] |
|
H1299 cells |
NOTCH-1↓, Jagged 1/2↓, Hey-1↓, Hes-1↓ |
[66] |
|
H1299, A549 cells |
EMT↓, p-Src↓, p-paxillin↓, p-FAK↓, MMP-2↓, MMP-9↓, slug↓, snail↓, ZEB1↓, twist↓ |
[67] |
|
HepG2 cells |
ApoB secretion (IC50 = 29 μM)↓, cholesterol synthesis (IC50 = 68 μM)↓, triglyceride synthesis (IC50 = 73 μM)↓ |
[39] |
Dyslipidemia↓, insulin resistance↓, atherogenesis↓, apoB100↓, MAPKerk↑, LDLR↑, MTP↓, DGAT1/2↓, Pgc1α↑, Cpt1α↑, β-oxidation↑ |
[51] |
|
Hepatocytes |
NO (IC50 = 50 μM)↓ |
[1] |
|
HFD-induced obese mice |
Plasma triglyceride↓, body weight gain↓, WAT weight↓, PPARα↑, PPARγ↑, fatty acid synthase↑, sterol regulatory element-binding protein-1c↑, stearoyl-CoA desaturase-1↑, adiponectin↑, carnitine palmitoyltransferase 1↑, uncoupling protein-2↑, monocyte chemoattractant protein-1↓, TNFα↓, GLUT4↑, p-Akt↑, IκBα degradation↓ |
[34] |
|
HL-60 cell line |
ERK↓, caspase-3↑, caspase-9↑, caspase-8↑, MAPK↑ |
[56] |
|
HOS and U2OS cells |
ERK/JNK↓, MMP-2↓, MMP-9↓, CREB↓, SP-1↓, NF-κB↓ |
[71] |
|
HT22 cells |
p-p38↓, p-JNK↓, Bax↓, caspase-3↓, Bcl-2↑, cognitive impairment↓, apoptosis↓ |
[22] |
|
HuH-7, SK-N-SH, 3Y1 |
Trib3 ↓, Ddit3↓, Asns↓, E2f8↓, Ccna2↓, Ccne2↓, Txnip↓ |
[87] |
|
Human intestinal mast cells |
CCL3↓, CCL4↓, CXCL8↓, IL-1β↓, TNFα↓ |
[42] |
|
Human ovarian cancer cells |
HIF-1α↓, Akt↓, NF-κB↓, VEGF↓ |
[64] |
|
Human fetal membranes and myometrium |
IL-1β↓, TNFα↓, IL-8↓, IL-6↓, MMP-9↓, COX-2↓, pro-MMP-9↓, PGE2↓ |
[65] |
|
Human dermal fibroblasts |
MMP-9↓, p-p38 MAPK↓ |
[92] |
|
L-Arginine-induced AP |
Plasma amylase↓, pancreatic myeloperoxidase↓, plasma proinflammatory factors↓, reactive oxygen species production↓, cell apoptosis↓, pancreatic necrosis↓, p-p38MAPK↓, p-AKT↓ |
[45] |
|
MDA-MB-231 cells |
MMP-9 (IC50 = 24 μM)↓, CXCR4 (IC50 = 32 μM)↓, MAPKs↓, NF-κB↓ |
[61] |
|
MDA-MB-468 cells |
ERK1/2↓, cyclin D1↓, p21↑, Bcl-xL↓, Akt↓, mTOR↓ |
[63] |
|
MPP+-triggered rat PD |
Microglia activation↓, dopaminergic neuron degeneration↓ |
[23] |
|
MPTP-triggered mice PD |
Dopamine release↑, Ca2+/CaMKII autophosphorylation↑, DARPP-32↑, TH↑, cognitive and motor functions↑ |
[24] |
|
NK leukemia cell |
Granzyme B↑, p38 MAPK↑, cytolytic activity of KHYG-1 cells↑ |
[57] |
|
NPC-BM, HONE-1 cells |
MMP-2↓, NF-κB↓, AP-1↓, TIMP-2↑ |
[69] |
|
Normal human melanocytes |
Tyrosinase↓, TRP1↓, PMEL↓, MITF↓, p-CREB↓, p-MEK/p-ERK1/2↓, p-Raf-1↓ |
[91] |
|
OVCAR-3, A2780/CP70 cells |
Cell Viability↓, proliferation↓, VEGF↓ |
[62] |
|
OVX mice |
Bone resorption↓, osteoclast formation↓, NF-κB↓, COX-2↓, PGE2↓ |
[70] |
|
P53-mutated SNU-16 human gastric cancer cells |
Proliferation↓, caspase-3↑, caspase-9↑, Bax/Bcl-2 ratio↑, PARP degradation↑, apoptosis↑ |
[43] |
|
PC12 cells |
Aβ
1-42 self-induced aggregation↓ |
[14] |
NR1↑, NR2A↑, NR2B↑, c-FOS↑, learning impairment↓, CRE-dependent transcription↑, PKA/ERK/MEK/CREB↑ |
[17] |
|
PC-3 cells |
Viability↓, VEGF↓, NF-κB↓, AKT/HIF-1α↓ |
[58] |
|
PDGF-BB treated VSMCs |
Proliferation↓, migration↓, ROS↓, p-ERK1/2↓, NF-κB p65 nuclear translocation↓ |
[53] |
|
Postischemic |
HO-1↑, Nrf2↑, GSH↑, SOD1↑, MMP-9↓, MDA↓, NF-κB↓, neurological deficits↓, brain edema↓ |
[11] |
|
Rats |
Hexokinase↑, succinate dehydrogenase↑, mitochondrial metabolism↑ |
[30] |
|
Rat I/R injury |
Infarct volume↓, brain edema↓, cell death↓ |
[20] |
CREB↑, Akt↑, BDNF↑, Bcl-2↑, neurological deficits↓, brain edema↓, BBB permeability↓ |
[21] |
|
Rat primary astrocytes |
iNOS↓, NO production↓, NF-κB↓, p38-MAPK phosphorylation↓ |
[6] |
|
RAW 264.7 cells |
NO (IC50 = 27 μM)↓ |
[46] |
Bone resorption↓, osteoclast formation↓, osteoclastogenesis↓ |
[8] |
|
RBL-2H3 cells |
IL-4↓, TNFα↓, AP-1↓, NF-κB↓, p38↓, PKC↓ |
[86] |
|
SAMP8 mice model |
Aging cognitive impairment↓, tau phosphorylation↓, oxidative stress↓ |
[12] |
|
SK-N-SH cells |
NEP↑ |
[15] |
TXNIP↓ |
[27] |
|
SMMC-7721 cells |
Proliferation↓, Bcl-2↓, COX-2↓, Bax↑, caspase-3↑ |
[48] |
|
STZ-induced C57BL mice |
TGFβ1↓, fibronectin↓, CTGF↓, collagen 1α↓, p22phox↓, p67phox↓, p91phox↓, p38 MAPK/JNK↓, NF-κB↓ |
[50] |
|
STZ-induced rats |
Oxidative stress↓, hemodynamic parameters↓, vascular reactivity↓, MMP-2↓, MMP-9↓, collagen↓ |
[10] |
|
TNBS-triggered colitis |
COX-2↓, iNOS↓, Akt-NF-κB-MLCK signaling↓ |
[41] |
|
U87, Hs683 glioma cells |
Cell viability↓, cyclin D1↓, E2 promoter-binding factor 1↓, CDK2↓, CDK4↓, p-PKB↓, p-p38 MAPK↓, p-ERK↓, p-JNK↓ |
[26] |